Baloxavir marboxil, sold under the brand name Xofluza, is an antiviral medication used for the treatment of influenza A and influenza B. It was approved for medical use both in Japan and in the United States in 2018, and is taken by mouth. It can reduce the duration of flu symptoms by about 1-2 days in some people, but can also develop selection of resistant mutants that render it ineffectual; however studies noted this was seen mostly in children that were studied.
Baloxavir marboxil, sold under the brand name Xofluza, is an antiviral medication used for the treatment of influenza A and influenza B. It was approved for medical use both in Japan and in the United States in 2018, and is taken by mouth. It can reduce the duration of flu symptoms by about 1-2 days in some people, but can also develop selection of resistant mutants that render it ineffectual; however studies noted this was seen mostly in children that were studied.
Source: Wikipedia "Baloxavir marboxil" · CC BY-SA 4.0
Share this article: X · Bluesky